Abametapir - Generic Drug Details

What are the generic sources for abametapir and what is the scope of freedom to operate?

Abametapir is the generic ingredient in one branded drug marketed by Hatchtech and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Abametapir has thirty-five patent family members in fifteen countries.

One supplier is listed for this compound.

Summary for abametapir

International Patents:	35
US Patents:	5
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	104
Clinical Trials:	6
Patent Applications:	566
What excipients (inactive ingredients) are in abametapir?	abametapir excipients list
DailyMed Link:	abametapir at DailyMed

Recent Clinical Trials for abametapir

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Dr. Reddy's Laboratories Limited	Phase 2
Hatchtech Pty Ltd	Phase 2
Syneos Health	Phase 3

See all abametapir clinical trials

US Patents and Regulatory Information for abametapir

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hatchtech	XEGLYZE	abametapir	LOTION;TOPICAL	206966-001	Jul 24, 2020		DISCN	Yes	No
Hatchtech	XEGLYZE	abametapir	LOTION;TOPICAL	206966-001	Jul 24, 2020		DISCN	Yes	No			Y	Y
Hatchtech	XEGLYZE	abametapir	LOTION;TOPICAL	206966-001	Jul 24, 2020		DISCN	Yes	No			Y
Hatchtech	XEGLYZE	abametapir	LOTION;TOPICAL	206966-001	Jul 24, 2020		DISCN	Yes	No			Y

International Patents for abametapir

Country	Patent Number	Title	Estimated Expiration
Japan	2007505032
South Africa	200706806	Methods and compositions for controlling ectoparasites
China	1822854	Methods and compositions for controlling ectoparasites
European Patent Office	3082424	COMPOSITION PEDICULICIDE (PEDICULICIDAL COMPOSITION)